BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Total Expenditure History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Expenditure | ₹308 Cr | ₹279 Cr | ₹257 Cr | ₹226 Cr | ₹166 Cr |
What is the latest Total Expenditure of BAL PHARMA ?
Year | Total Expenditure |
---|---|
Mar2024 | ₹308 Cr |
Mar2023 | ₹279 Cr |
Mar2022 | ₹257 Cr |
Mar2021 | ₹226 Cr |
Mar2020 | ₹166 Cr |
How is Total Expenditure of BAL PHARMA Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2024 | ₹308 Cr | 10.23 | |
Mar2023 | ₹279 Cr | 8.45 | |
Mar2022 | ₹257 Cr | 13.88 | |
Mar2021 | ₹226 Cr | 36.02 | |
Mar2020 | ₹166 Cr | - |
Compare Total Expenditure of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹216.1 Cr | 13.5% | 11.8% | 25.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | 13.5% |
11.8% |
25.7% |
SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses